机译:系统患者参与本土门诊施用复合化疗急性白血病和淋巴瘤
Department of HaematologyUniversity Hospital of Copenhagen Rigshospitalet DenmarkCopenhagen Denmark;
Department of HaematologyUniversity Hospital of Copenhagen Rigshospitalet DenmarkCopenhagen Denmark;
Department of HaematologyUniversity Hospital of Copenhagen Rigshospitalet DenmarkCopenhagen Denmark;
Department of HaematologyUniversity Hospital of Copenhagen Rigshospitalet DenmarkCopenhagen Denmark;
Department of HaematologyUniversity Hospital of Copenhagen Rigshospitalet DenmarkCopenhagen Denmark;
Department of HaematologyUniversity Hospital of Copenhagen Rigshospitalet DenmarkCopenhagen Denmark;
Department of HaematologyUniversity Hospital of Copenhagen Rigshospitalet DenmarkCopenhagen Denmark;
Department of HaematologyUniversity Hospital of Copenhagen Rigshospitalet DenmarkCopenhagen Denmark;
Department of Clinical MicrobiologyUniversity Hospital of Copenhagen Rigshospitalet;
Department of HaematologyUniversity Hospital of Copenhagen Rigshospitalet DenmarkCopenhagen Denmark;
The University Hospitals Centre for Health ResearchCopenhagen Denmark;
acute leukaemia; HSC transplantation; chemotherapy; patient involvement; programmable infusion pump;
机译:系统患者参与自制的门诊施用复合化疗急性白血病和淋巴瘤
机译:重组人可溶性血栓调节素α(Recomodulin)在老年急性单细胞白血病涉及t(9; 11)(p22; q23)MLL / AF9易位的老年患者的诱导化疗期间用于弥散性血管内凝血的成功给药
机译:肥胖成人急性白血病或淋巴瘤患者以体重为基础的化疗方案对治疗结果的系统评价
机译:儿童口服泼尼松过程中对急性淋巴细胞白血病模型的患者个性化:启动ALL Oncosimulator
机译:培养的人类免疫细胞,培养的人类急性淋巴细胞白血病细胞和急性粒细胞性白血病患者呼气中的挥发性生物标志物
机译:重组人可溶性血栓调节素α(Recomodulin)在老年急性单细胞白血病涉及t(9; 11)(p22; q23)MLL / AF9易位的老年患者诱导化疗期间用于弥散性血管内凝血的成功给药
机译:系统患者参与本土门诊施用复合化疗急性白血病和淋巴瘤